Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person8
Lucid Diagnostics Inc.
Company
Co-Diagnostics, Inc.
Company
QUEST DIAGNOSTICS INC
Company
Bluejay Diagnostics, Inc.
Company
Cardio Diagnostics Holdings, Inc.
Company
Insight Molecular Diagnostics Inc.
Company
Lucid Group, Inc.
Company
SERA PROGNOSTICS, INC.
Company
Primary record5
Lucid Diagnostics Inc. filed 8-K
Item 3.02. Unregistered Sales of Equity Securities. On October 21, 2026, the Company entered into subscription agreements (each, a “ Series C Subscription Agreement ”) with certain accredited investors (collectively, the
PAVmed Inc. filed 8-K
Item 1.01. Entry into a Material Definitive Agreement. Effective as of October 21, 2026, Lucid Diagnostics Inc. (the “ Lucid Diagnostics ”), a subsidiary of PAVmed Inc. (the “ Company ”), entered into subscription agreem
Lucid Diagnostics Inc. filed 8-K
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On October 12, 2026, Lucid Diagnostics Inc. (the “ Company ”) received a notice from the Listing Qualificati
Lucid Diagnostics Inc. filed 8-K
Item 7.01. Regulation FD Disclosure. On September 22, 2026, Lucid Diagnostics Inc. (the Company ) issued a press release announcing advances in multiple payment, billing, and coding pathways for its EsoGuard Esophageal D
Lucid Diagnostics Inc. filed 8-K
Item 2.02 Results of Operations and Financial Condition. On August 13, 2026, Lucid Diagnostics Inc. (the “ Company ”) issued a press release announcing financial results for its fiscal quarter ended June 30, 2026 and pro